Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer

[1]  R. Moriggl,et al.  Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas , 2017, Expert opinion on therapeutic targets.

[2]  Catarina P. Santos,et al.  Synthetic lethality between the cohesin subunits STAG1 and STAG2 in diverse cancer contexts , 2017, bioRxiv.

[3]  W. Vainchenker,et al.  Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms. , 2017, Blood.

[4]  L. Hennighausen,et al.  Lineage-Specific and Non-specific Cytokine-Sensing Genes Respond Differentially to the Master Regulator STAT5. , 2016, Cell reports.

[5]  R. Xing,et al.  STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer , 2016, Molecular Cancer.

[6]  Mingming Jia,et al.  COSMIC: somatic cancer genetics at high-resolution , 2016, Nucleic Acids Res..

[7]  R. Siebert,et al.  Genes encoding members of the JAK‐STAT pathway or epigenetic regulators are recurrently mutated in T‐cell prolymphocytic leukaemia , 2016, British journal of haematology.

[8]  X. Bian,et al.  Genome-wide Analysis Identifies Bcl6-Controlled Regulatory Networks during T Follicular Helper Cell Differentiation. , 2016, Cell reports.

[9]  B. Göttgens,et al.  Cytokine‐induced megakaryocytic differentiation is regulated by genome‐wide loss of a uSTAT transcriptional program , 2015, The EMBO journal.

[10]  Christopher J. Ott,et al.  Dose-dependent role of the cohesin complex in normal and malignant hematopoiesis , 2015, The Journal of experimental medicine.

[11]  E. Zandi,et al.  Hydrogen Sulfide Promotes Tet1- and Tet2-Mediated Foxp3 Demethylation to Drive Regulatory T Cell Differentiation and Maintain Immune Homeostasis. , 2015, Immunity.

[12]  T. Ikezoe,et al.  STAT5A regulates DNMT3A in CD34(+)/CD38(-) AML cells. , 2015, Leukemia research.

[13]  Jer-Yen Yang,et al.  Leptin-STAT3-G9a Signaling Promotes Obesity-Mediated Breast Cancer Progression. , 2015, Cancer research.

[14]  G. Stark,et al.  STAT3-driven transcription depends upon the dimethylation of K49 by EZH2 , 2015, Proceedings of the National Academy of Sciences.

[15]  K. Basso,et al.  Germinal centres and B cell lymphomagenesis , 2015, Nature Reviews Immunology.

[16]  A. Jegga,et al.  Activated STAT5 Confers Resistance to Intestinal Injury by Increasing Intestinal Stem Cell Proliferation and Regeneration , 2015, Stem cell reports.

[17]  D. Levy,et al.  STAT3 supports experimental K-RasG12D-induced murine myeloproliferative neoplasms dependent on serine phosphorylation. , 2014, Blood.

[18]  G. Stark,et al.  Critical Role for Lysine 685 in Gene Expression Mediated by Transcription Factor Unphosphorylated STAT3* , 2014, The Journal of Biological Chemistry.

[19]  Zhaohui S. Qin,et al.  Reciprocal occupancy of BCL6 and STAT5 on Growth Hormone target genes: contrasting transcriptional outcomes and promoter-specific roles of p300 and HDAC3 , 2014, Molecular and Cellular Endocrinology.

[20]  A. Rudensky,et al.  Control of the Inheritance of Regulatory T Cell Identity by a cis Element in the Foxp3 Locus , 2014, Cell.

[21]  R. Lai,et al.  STAT3 in Cancer—Friend or Foe? , 2014, Cancers.

[22]  C. Pecquet,et al.  Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulation , 2014, Oncogene.

[23]  E. Cheung,et al.  Estrogen receptor-mediated long-range chromatin interactions and transcription in breast cancer , 2014, Molecular and Cellular Endocrinology.

[24]  D. Frank,et al.  Distinct roles of STAT3 and STAT5 in the pathogenesis and targeted therapy of breast cancer , 2014, Molecular and Cellular Endocrinology.

[25]  S. Bhattacharyya,et al.  FoxP3 acts as a cotranscription factor with STAT3 in tumor-induced regulatory T cells. , 2013, Immunity.

[26]  R. Young,et al.  Super-Enhancers in the Control of Cell Identity and Disease , 2013, Cell.

[27]  D. Nam,et al.  Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. , 2013, Cancer cell.

[28]  H. Land,et al.  Unphosphorylated STAT5A stabilizes heterochromatin and suppresses tumor growth , 2013, Proceedings of the National Academy of Sciences.

[29]  Guocheng Yuan,et al.  STAT5 Outcompetes STAT3 To Regulate the Expression of the Oncogenic Transcriptional Modulator BCL6 , 2013, Molecular and Cellular Biology.

[30]  P. Sehgal.  Non-genomic STAT5-dependent effects at the endoplasmic reticulum and Golgi apparatus and STAT6-GFP in mitochondria , 2013, JAK-STAT.

[31]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[32]  L. Hennighausen,et al.  Comprehensive meta-analysis of Signal Transducers and Activators of Transcription (STAT) genomic binding patterns discerns cell-specific cis-regulatory modules , 2013, BMC Genomics.

[33]  J. Carroll,et al.  Pioneer factors in hormone-dependent cancers , 2012, Nature Reviews Cancer.

[34]  A. Riggs,et al.  Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation , 2012, Proceedings of the National Academy of Sciences.

[35]  Kairong Cui,et al.  Critical Role of STAT5 transcription factor tetramerization for cytokine responses and normal immune function. , 2012, Immunity.

[36]  J. Darnell,et al.  The JAK-STAT pathway at twenty. , 2012, Immunity.

[37]  D. Levy,et al.  Nongenomic STAT5-dependent effects on Golgi apparatus and endoplasmic reticulum structure and function. , 2012, American journal of physiology. Cell physiology.

[38]  Hai Qi,et al.  STAT5 Protein Negatively Regulates T Follicular Helper (Tfh) Cell Generation and Function* , 2012, The Journal of Biological Chemistry.

[39]  L. Hennighausen,et al.  Genome-wide analyses reveal the extent of opportunistic STAT5 binding that does not yield transcriptional activation of neighboring genes , 2012, Nucleic acids research.

[40]  K. Oestreich,et al.  Molecular mechanisms that control the expression and activity of Bcl-6 in TH1 cells to regulate flexibility with a TFH-like gene profile , 2012, Nature Immunology.

[41]  R. Moriggl,et al.  Enterocyte STAT5 promotes mucosal wound healing via suppression of myosin light chain kinase-mediated loss of barrier function and inflammation , 2012, EMBO molecular medicine.

[42]  E. Yeh,et al.  SUMO-specific protease 1 is critical for early lymphoid development through regulation of STAT5 activation. , 2012, Molecular cell.

[43]  Zhaoyu Li,et al.  Foxa1 and Foxa2 Are Essential for Sexual Dimorphism in Liver Cancer , 2012, Cell.

[44]  D. Waxman,et al.  Dynamic, Sex-Differential STAT5 and BCL6 Binding to Sex-Biased, Growth Hormone-Regulated Genes in Adult Mouse Liver , 2011, Molecular and Cellular Biology.

[45]  A. Dinner,et al.  Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2 , 2011, Nature Immunology.

[46]  D. Schübeler,et al.  Determinants and dynamics of genome accessibility , 2011, Nature Reviews Genetics.

[47]  Daeyoup Lee,et al.  Decoding the genome with an integrative analysis tool: Combinatorial CRM Decoder , 2011, Nucleic acids research.

[48]  James Douglas Engel,et al.  Nuclear Receptors TR2 and TR4 Recruit Multiple Epigenetic Transcriptional Corepressors That Associate Specifically with the Embryonic β-Type Globin Promoters in Differentiated Adult Erythroid Cells , 2011, Molecular and Cellular Biology.

[49]  G. Blandino,et al.  Chromatin Dynamics of Gene Activation and Repression in Response to Interferon α (IFNα) Reveal New Roles for Phosphorylated and Unphosphorylated Forms of the Transcription Factor STAT2* , 2011, The Journal of Biological Chemistry.

[50]  J. O’Shea,et al.  Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5 , 2011, Nature Immunology.

[51]  G. Stark,et al.  The functions of signal transducers and activators of transcriptions 1 and 3 as cytokine-inducible proteins. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[52]  P. Ferrigno,et al.  The role of BCL6 in lymphomas and routes to therapy , 2011, British journal of haematology.

[53]  G. Stark,et al.  Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes , 2010, Proceedings of the National Academy of Sciences.

[54]  S. Zhuang,et al.  Acetylation modulates prolactin receptor dimerization , 2010, Proceedings of the National Academy of Sciences.

[55]  Ernest Fraenkel,et al.  Unbiased, Genome-Wide In Vivo Mapping of Transcriptional Regulatory Elements Reveals Sex Differences in Chromatin Structure Associated with Sex-Specific Liver Gene Expression , 2010, Molecular and Cellular Biology.

[56]  C. Pecquet,et al.  miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets. , 2010, Blood.

[57]  J. O’Shea,et al.  Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. , 2010, Immunity.

[58]  H. Rui,et al.  Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism. , 2010, Cancer research.

[59]  A. Strasser,et al.  Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development , 2010, Nature Immunology.

[60]  L. Hennighausen,et al.  Essential role for Stat5a/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2(V617F) in mice. , 2009, Blood.

[61]  D. Levy,et al.  Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation , 2009, Science.

[62]  G. Stark,et al.  Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes , 2009, Proceedings of the National Academy of Sciences.

[63]  P. Fawcett,et al.  Function of Mitochondrial Stat3 in Cellular Respiration , 2009, Science.

[64]  N. Watanabe,et al.  SHD1 is a novel cytokine-inducible, negative feedback regulator of STAT5-dependent transcription. , 2009, Blood.

[65]  H. Beug,et al.  Stat5 regulates cellular iron uptake of erythroid cells via IRP-2 and TfR-1. , 2008, Blood.

[66]  L. Kenner,et al.  Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade. , 2008, Blood.

[67]  S. Lim,et al.  Drosophila STAT is required for directly maintaining HP1 localization and heterochromatin stability , 2008, Nature Cell Biology.

[68]  L. Hennighausen,et al.  Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B. , 2008, Genes & development.

[69]  G. Stark,et al.  Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. , 2007, Genes & development.

[70]  L. Hennighausen,et al.  Direct glucocorticoid receptor-Stat5 interaction in hepatocytes controls body size and maturation-related gene expression. , 2007, Genes & development.

[71]  Gratien G. Prefontaine,et al.  Opposing LSD1 complexes function in developmental gene activation and repression programmes , 2007, Nature.

[72]  Z. Otwinowski,et al.  Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase. , 2006, Molecular cell.

[73]  M. Wasik,et al.  STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes. , 2006, Blood.

[74]  A. Brasier,et al.  STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen. , 2005, Gastroenterology.

[75]  M. Wasik,et al.  STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[76]  M. Lazar,et al.  Structural insights into the interaction and activation of histone deacetylase 3 by nuclear receptor corepressors , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[77]  V. Moucadel,et al.  Differential STAT5 Signaling by Ligand-dependent and Constitutively Active Cytokine Receptors* , 2005, Journal of Biological Chemistry.

[78]  Jianyuan Luo,et al.  Activation of Stat3 Sequence-specific DNA Binding and Transcription by p300/CREB-binding Protein-mediated Acetylation* , 2005, Journal of Biological Chemistry.

[79]  J. Darnell,et al.  Structural bases of unphosphorylated STAT1 association and receptor binding. , 2005, Molecular cell.

[80]  B. Blom,et al.  STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression , 2005, Nature Immunology.

[81]  Y. E. Chin,et al.  Stat3 Dimerization Regulated by Reversible Acetylation of a Single Lysine Residue , 2005, Science.

[82]  T. Barth,et al.  [Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in MedB-1 mediastinal lymphoma line]. , 2004, Verhandlungen der Deutschen Gesellschaft fur Pathologie.

[83]  David A. Frank,et al.  Genome-wide analysis of STAT target genes: Elucidating the mechanism of STAT-mediated oncogenesis , 2004, Cancer biology & therapy.

[84]  J. Li,et al.  Transcriptional inactivation of STAT3 by PPARgamma suppresses IL-6-responsive multiple myeloma cells. , 2004, Immunity.

[85]  I. Dusanter-Fourt,et al.  STAT5 and Oct-1 Form a Stable Complex That Modulates Cyclin D1 Expression , 2003, Molecular and Cellular Biology.

[86]  C. Litterst,et al.  NCoA-1/SRC-1 Is an Essential Coactivator of STAT5 That Binds to the FDL Motif in the α-Helical Region of the STAT5 Transactivation Domain* , 2003, Journal of Biological Chemistry.

[87]  Heinz Baumann,et al.  Signal transducer and activator of transcription proteins in leukemias. , 2003, Blood.

[88]  Monilola A. Olayioye,et al.  CPAP is a novel stat5-interacting cofactor that augments stat5-mediated transcriptional activity. , 2002, Molecular endocrinology.

[89]  J. Ihle,et al.  Functional interaction of STAT5 and nuclear receptor co‐repressor SMRT: implications in negative regulation of STAT5‐dependent transcription , 2001, The EMBO journal.

[90]  J. Rosen,et al.  Cooperative Effects of STAT5 (Signal Transducer and Activator of Transcription 5) and C/EBP β (CCAAT/Enhancer-Binding Protein-β) onβ -Casein Gene Transcription Are Mediated by the Glucocorticoid Receptor , 2001 .

[91]  J. Turkson,et al.  STAT proteins: novel molecular targets for cancer drug discovery , 2000, Oncogene.

[92]  E. Verdin,et al.  BCoR, a novel corepressor involved in BCL-6 repression. , 2000, Genes & development.

[93]  S. Moro,et al.  DNA Binding Site Selection of Dimeric and Tetrameric Stat5 Proteins Reveals a Large Repertoire of Divergent Tetrameric Stat5a Binding Sites , 2000, Molecular and Cellular Biology.

[94]  J. Darnell,et al.  The Significance of Tetramerization in Promoter Recruitment by Stat5 , 1999, Molecular and Cellular Biology.

[95]  B. Groner,et al.  p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response. , 1998, Molecular endocrinology.

[96]  J. Darnell,et al.  Structure of the amino-terminal protein interaction domain of STAT-4. , 1998, Science.

[97]  J. O’Shea.  Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? , 1997, Immunity.

[98]  N. Copeland,et al.  Distribution of the mammalian Stat gene family in mouse chromosomes. , 1995, Genomics.

[99]  G. Ferbeyre,et al.  The role of Stat5 transcription factors as tumor suppressors or oncogenes. , 2011, Biochimica et biophysica acta.

[100]  S. Karnik,et al.  Role of nuclear unphosphorylated STAT3 in angiotensin II type 1 receptor-induced cardiac hypertrophy. , 2010, Cardiovascular research.

[101]  Todd,et al.  Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning , 2002, Nature Medicine.

[102]  J. Rosen,et al.  Cooperative effects of STAT5 (signal transducer and activator of transcription 5) and C/EBPbeta (CCAAT/enhancer-binding protein-beta) on beta-casein gene transcription are mediated by the glucocorticoid receptor. , 2001, Molecular endocrinology.